Section Arrow
Quote
ARWR.NASDAQ
- Arrowhead Pharmaceuticals
Quotes are at least 15-min delayed:2025/03/28 00:16 EDT
Last
 13.8
-0.13 (-0.93%)
Day High 
14 
Prev. Close
13.93 
1-M High
19.965 
Volume 
1.44M 
Bid
13.7
Ask
14.55
Day Low
13.68 
Open
13.99 
1-M Low
13.74 
Market Cap 
1.91B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 15.07 
20-SMA 16.07 
50-SMA 18.3 
52-W High 30.41 
52-W Low 13.68 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.15/-3.92
Enterprise Value
2.42B
Balance Sheet
Book Value Per Share
0.38
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.55M
Operating Revenue Per Share
1.87
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed：2025/03/28 00:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.